期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
智慧养猪与智能猪场的应用现状与分析 被引量:2
1
作者 陈红跃 冯露秋 +7 位作者 张晨 王乃秀 汪凯 林海烂 黄子晴 何道领 朱燕 甘玲 《猪业科学》 2021年第9期30-33,共4页
在智能信息化时代,传统的人工养殖已经越发彰显其劣势。智慧养猪开启的智能装备和大数据模式正走进养猪人的视野。文章综述了在智慧养猪背景下,智能饲喂系统、环控系统、监控系统、AI和大数据在猪场的应用现状,并进行了简要分析,以期为... 在智能信息化时代,传统的人工养殖已经越发彰显其劣势。智慧养猪开启的智能装备和大数据模式正走进养猪人的视野。文章综述了在智慧养猪背景下,智能饲喂系统、环控系统、监控系统、AI和大数据在猪场的应用现状,并进行了简要分析,以期为农牧公司智能猪场的建设提供参考。 展开更多
关键词 智慧养猪 智能猪场 饲喂系统 环控系统 监控系统
下载PDF
Efficacy of percutaneous ethanol injection in the adjuvant treatment of hepatocellular carcinoma after TACE 被引量:2
2
作者 Mingzhi Hao hailan lin +6 位作者 Youhong Shen linan Tang Ruoyuan Yan Jianxiong Zheng Ojzhong Chen Jing Chen Zhougui Wu 《The Chinese-German Journal of Clinical Oncology》 CAS 2009年第2期69-72,共4页
Objective: To evaluate the efficacy of percutaneous ethanol injection (PEI) in the adjuvant treatment of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) by primary end point... Objective: To evaluate the efficacy of percutaneous ethanol injection (PEI) in the adjuvant treatment of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) by primary end points of time to progress (TTP). Methods: The study population consisted of 73 consecutive patients with inoperable HCC (China Classification System IIN liB). Among them, 22 patients were treated with TACE and PEI (experimental group), and the rest 51 were treated only with TACE (control group), and then the time to progress (TTP) and overall survival (OS) of these two groups were analyzed. Results: The median TTP was 10 months [95% confidence interval (CI), 7.9-12.1 months] in experimental group and 6 months (95% CI, 4.7-7.3 months) in control group. The 3-month,6-month, and 1-year Progression Free Survival (PFS) rates were respectively 77.3%, 63.6%, and 48.1% in experimental group, and 76.5%, 42.15%, and 24.8% in control group. The TTP of experimental group was significantly longer than that of control group (P 〈 0.05). The median survival period was 17 months [95% confidence interval (CI), 11-23 months] of experimental group and 12 months (95% CI, 10-14 months) of control group (P 〉 0.05). Conclusion: Compared with single TACE, the combination of TACE and PEI can obviously postpone disease progress and prolong survival of HCC patients. 展开更多
关键词 CARCINOMA HEPATOCELLULAR CHEMOEMBOLIZATION THERAPEUTIC ETHANOL time to progress progression free survival postembolization syndrome
下载PDF
Efficacy of transcatheter arterial chemoembolization combined with ganfule on advanced hepatocellular carcinoma
3
作者 Mingzhi Hao hailan lin +4 位作者 Qizhong Chen Yubin Hu Dong Zhou Ping Huang YunBin Ye 《The Chinese-German Journal of Clinical Oncology》 CAS 2013年第1期25-29,共5页
Objective: The aim of this study was to evaluate the efficacy of transcatheter arterial chemoembolization (TACE) combined with a Chinese compound preparation of ganfule on advanced hepatocellular carcinoma (HCC).... Objective: The aim of this study was to evaluate the efficacy of transcatheter arterial chemoembolization (TACE) combined with a Chinese compound preparation of ganfule on advanced hepatocellular carcinoma (HCC). Methods: The study population consisted of 132 advanced HCC patients with Child-pugh NB. Tumor in all patients was involved with main trunk of portal vein and/or inferior vena cava, or local lymph node metastasis, or distant metastasis. TACE combined with ganfule were performed in 65 patients with advanced HCC (interventional treatment group), 67 patients were treated with traditional Chinese herbal drug alone (Chinese herb group). The prime end point was overall survival (OS), and prognostic factors were analyzed. Results: The median OS was 205 days [95% confidence interval (CI), 155-255 days] in interventional treatment group and 127 days (95% CI, 70-184 days) in Chinese herb group (P 〈 0.05). The 6-month, 1-year, and 2-year OS rates were 58.9%, 29.1%, 7.7% in interventional treatment group, and 33.3%, 12.3%, 1.8% in Chinese herb group, respectively. The portal vein thrombosis, ECOG performance status (PS) were independent prognostic factors for OS. Conclusion: Ttranscatheter arterial chemoembolization combined with a Chinese compound preparation of ganfule could greatly prolong the OS of advanced HCC patients. The portal vein thrombosis and ECOG PS were independent prognostic factors for OS. 展开更多
关键词 liver neoplasm CHEMOEMBOLIZATION transcatheter arterial infusion Chinese herbs GANFULE
下载PDF
用原位聚合法制备的PA6/GO纳米复合材料的结构和性能 被引量:3
4
作者 黄欢 陈宇哲 +5 位作者 郭怡 蔺海兰 王丽君 马素德 卞军 谷志杰 《材料研究学报》 EI CAS CSCD 北大核心 2019年第8期621-628,共8页
以己内酰胺(CL)和6-氨基己酸(ACA)为聚合反应单体,用Hummers法制备氧化石墨烯(GO),再以GO为纳米填料用原位开环聚合法制备了GO改性PA6纳米复合材料(PA6/GO),并对PA6/GO纳米复合材料的结构及性能进行了研究。结果表明,PA6的黏均分子量达... 以己内酰胺(CL)和6-氨基己酸(ACA)为聚合反应单体,用Hummers法制备氧化石墨烯(GO),再以GO为纳米填料用原位开环聚合法制备了GO改性PA6纳米复合材料(PA6/GO),并对PA6/GO纳米复合材料的结构及性能进行了研究。结果表明,PA6的黏均分子量达到104数量级,但加入过多的GO使PA6的分子量降低。形貌分析表明,GO均匀地分散在PA6基体中,并诱导了PA6基体的晶型由α晶型转变成γ晶型。同时,GO作为异相成核剂促进了PA6/GO复合材料中PA6基体的结晶,提高了PA6/GO复合材料的结晶度。拉伸测试结果表明,随着GO的加入PA6/GO纳米复合材料的拉伸强度先提高后降低,GO加入量为0.4份时拉伸强度达到最大值61.72 MPa,比纯PA6(48.52 MPa)提高了27.21%。导热性能分析表明含1.0份GO的PA6/GO纳米复合材料其50℃和100℃的热导率分别为0.317 W/(m·K)和0.280 W/(m·K),较纯PA6分别提高了33.19%和33.23%。 展开更多
关键词 复合材料 尼龙6(PA6) 氧化石墨烯(GO) 力学性能 导热性能
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部